Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-10-01
1987-12-15
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 69, A61K 3148, C07D45704
Patent
active
047133848
ABSTRACT:
Method of blocking 5HT without effect on alpha receptors with 1-loweralkyl-6-straight chain alkyl-8.beta.-hydroxycycloalkyloxycarbonylergolines.
REFERENCES:
patent: 3113133 (1963-12-01), Hofmann et al.
patent: 3183234 (1965-05-01), Garbrecht et al.
patent: 3228941 (1966-01-01), Bernardi et al.
patent: 3249617 (1966-05-01), Hofmann et al.
patent: 3580916 (1971-05-01), Garbrecht
patent: 4230859 (1980-10-01), Rucman
patent: 4563461 (1986-01-01), Cohea et al.
Cohen, Drug Developement Res., 5, 313, (1985), (Cohen IV).
Cohen et al., J.P.E.T., 232, 770, (1985), (Cohen III).
Berde, The Medical Journal of Australia, Special Supplement, Nov. 4, 1978, pp. 3-13.
Fanciullacci et al., Headache, 16, 226, (1976).
Calesnick, AFP, 25, 228, (1982).
Awouters, 5-Hydroxytryptamine in Perpheral Reactions (Raven Press, N.Y., 1982), pp. 71-75.
Aellig, Eur. J. Clin. Pharm., 25, 759, (1983).
Sulman et al., Headache, 17, 203, (1979).
Amano et al., ibid, 22, 249, (1982).
Cohen et al., J.P.E.T., 227, 327, (1983), (Cohen I).
Lance, Brit. Med. J., 1970, (2), 327, (Lance I).
Saxena, ibid, 12, 44, (1972).
Lance and Anthony, Proc. Aust. Assoc. Neurol., 7, 32, (1970).
Prusinski et al., Pol. J. Pharmacol. Pharm., 37, Suppl. 189-193.
Harriet F. Lemberger et al., Life Sci., 35, 71, (1984).
Hingten et al., Soc. for Neuroscience Abstract, 374, p. 125, (1983).
Cohen Marlene L.
Fuller Ray W.
Garbrecht William L.
Whitten Kathleen R.
Barclay Bruce J.
Daus Donald G.
Eli Lilly and Company
Shen Cecilia
Whitaker Leroy
LandOfFree
Selective method for blocking 5HT.sub.2 receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective method for blocking 5HT.sub.2 receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective method for blocking 5HT.sub.2 receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1220414